PATENT CLAIM ANALYSIS

Application Number: 15993059
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "475000"]

Abstract:
The present invention relates to modified or polymer conjugated MetAP2 inhibitors. The present invention also relates to methods of preventing, inducing, causing or increasing weight loss, treating obesity and/or treating metabolic syndrome utilizing the modified or polymer conjugated MetAP2 inhibitors. The present invention also relates to methods of improving insulin sensitivity and glycemic control, reducing insulin levels and/or improving leptin sensitivity utilizing the modified or polymer conjugated MetAP2 inhibitors.

Claim (Index 11):
The method of  claim 8 , wherein AA 5  is phenylalanine and AA 6  is glycine.

Metadata:
- Claim Count in Document: 143.0
- Percentile: 93.0
- Lexical Diversity: 2.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15665755', '15226258', '14851668', '14248787', '15226267']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8640743179131045
- 35 USC 102 Novelty (BERT): 0.6234738048518912
- Combined Prediction Score: 0.8400142666069832
- Mean Citation Score: 579.961532
- Max Citation Score: 581.8517
- Similarity Product: 533.1150251738907

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test